# Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

> **NCT01192243** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 68 (estimated)

## Conditions studied

- Toxicity
- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Gefitinib
- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin or carboplatin

## Key facts

- **NCT ID:** NCT01192243
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2010-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01192243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01192243, "Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01192243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*